CAVAZZANA, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 4.818
NA - Nord America 4.159
AS - Asia 878
AF - Africa 9
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 9.878
Nazione #
US - Stati Uniti d'America 4.143
IT - Italia 3.219
CN - Cina 537
UA - Ucraina 472
DE - Germania 314
HK - Hong Kong 175
FR - Francia 162
IE - Irlanda 161
FI - Finlandia 158
GB - Regno Unito 149
SG - Singapore 105
RU - Federazione Russa 37
IN - India 31
SE - Svezia 30
RO - Romania 18
ES - Italia 17
BE - Belgio 15
CA - Canada 15
CH - Svizzera 10
NL - Olanda 9
PL - Polonia 9
VN - Vietnam 8
MK - Macedonia 7
EG - Egitto 6
TR - Turchia 6
LU - Lussemburgo 5
AT - Austria 4
BR - Brasile 4
EU - Europa 4
GR - Grecia 4
CZ - Repubblica Ceca 3
IL - Israele 3
IR - Iran 3
LI - Liechtenstein 3
SI - Slovenia 3
AU - Australia 2
DK - Danimarca 2
JO - Giordania 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
ID - Indonesia 1
JP - Giappone 1
MS - Montserrat 1
MU - Mauritius 1
NO - Norvegia 1
UG - Uganda 1
Totale 9.878
Città #
Fairfield 640
Woodbridge 400
Jacksonville 377
Ashburn 323
Houston 292
Seattle 252
Cambridge 235
Wilmington 216
Princeton 189
Ann Arbor 186
Milan 181
Hong Kong 174
Chandler 164
Rome 150
Beijing 129
Nanjing 122
New York 116
Helsinki 115
Dublin 99
Florence 96
Brescia 66
Singapore 54
Trieste 52
Nanchang 40
Des Moines 36
Turin 36
Verona 36
San Diego 34
Udine 34
Genoa 33
Hebei 32
Lancaster 32
Shanghai 32
Shenyang 32
Padova 30
Tianjin 27
Bologna 25
Dearborn 24
Los Angeles 24
Genova 23
London 23
Pisa 23
Bergamo 22
Changsha 22
Syracuse 21
Menlo Park 20
Jinan 19
Reggio Nell'emilia 18
Jiaxing 16
Munich 16
San Francisco 16
Torino 16
Brussels 15
Redwood City 15
Trento 14
Mumbai 13
Modena 12
Toronto 12
Bari 11
Ferrara 11
Catania 10
Cosenza 10
Desio 10
Hangzhou 10
Kunming 10
Orange 10
Pozzuolo Del Friuli 10
Sassari 10
Venice 10
Washington 10
Lappeenranta 9
Naples 9
Ningbo 9
Palermo 9
Rho 9
Turriaco 9
Dong Ket 8
Fiumicino 8
Francenigo 8
Napoli 8
Norwalk 8
Nürnberg 8
Perugia 8
Cagliari 7
Dallas 7
Lecco 7
Manresa 7
Pune 7
Boardman 6
Bucharest 6
Cairo 6
Caserta 6
Cernobbio 6
Cervignano del Friuli 6
Duncan 6
Montegranaro 6
Pescara 6
Piemonte 6
Pordenone 6
Prato 6
Totale 5.810
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.046
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.483
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 148
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 139
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 129
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 120
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 118
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 117
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 117
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 115
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 114
The clinico-serological spectrum of overlap myositis 114
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 113
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 110
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 109
Endothelium and the brain in CNS lupus. 106
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 104
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 102
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 102
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 101
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 100
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 98
Renal Involvement in Primary Antiphospholipid Syndrome: Retrospective Analysis of 160 Patients. 97
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 95
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 95
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 95
Autoantibodies and Skin Involvement in Systemic Autoimmune Diseases 92
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 91
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 89
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 88
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 88
Anti-Ro/SSA and La/SSB antibodies 88
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 87
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 86
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 84
Update on Antiphospholipid Syndrome: Ten Topics in 2017 84
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 84
Serologic profile and mortality rates of scleroderma renal crisis in Italy 83
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 80
Complement Activation and Pregnancy Failure. 78
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 78
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 76
Diastolic dysfunction in rheumatoid arthritis: a usual travel-mate? 75
Complement cascade in systemic lupus erythematosus: Analyses of the three activation pathways 68
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 68
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 68
CLINICAL AND IMMUNOLOGICAL ASSOCIATION WITH AUTOANTIBODIES TO CELLULAR ANTIGEN IN A COHORT OF 532 SLE PATIENTS FROM A SINGLE CENTER 65
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 65
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 64
Una rara causa di shock cardiogeno in una giovane donna. 62
Rare Autoantibodies To Cellular Antigens In Systemic Lupus Erythematosous. 62
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 61
Ten Year Risk of Cardiovascular Events during anti-TNF Alpha in Rheumatoid Arthritis Patients 60
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 58
Comparison of early and late onset systemic lupus erythematosus 58
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 57
Left ventricular function in rheumatoid arthritis during anti-TNF-α treatment: a speckle tracking prospective echocardiographic study. 55
FIRST REPORT OF ANTI-MDA5 ANTIBODIES IN A COHORT OF ITALIAN PATIENTS WITH DERMATOMYOSITIS: CLINICAL AND SEROLOGIC CORRELATIONS 55
INTERESSAMENTO RENALE NELLA SINDROME DA ANTI-FOSFOLIPIDI PRIMARIA 54
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 54
CONNETTIVITE INDIFFERENZIATA (UCTD) DI RECENTE DIAGNOSI: PROFILO CLINICO ED IMMUNOLOGICO 53
Renal involvement in primary anti-phospholipid syndrome 53
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 52
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 52
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 51
DETECTION OF ANTI-ARGONAUTE2 (AGO2/SU) AND -RO ANTIBODIES BY IMMUNOPRECIPITATION, IN PRIMARY ANTI-PHOSPHOLIPID SYNDROME (PAPS) PATIENTS: ARE THEY PREDICTIVE FOR EVOLUTION IN SYSTEMIC LUPUS ERYTHEMATOSUS? 51
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 50
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 48
Antibodies against antigens related to Scleroderma in a cohort of patients with Morphea 48
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 45
LEFT VENTRICULAR FUNCTION IN RHEUMATOID ARTHRITIS DURING ANTI-TNF ALPHA TREATMENT: PROSPECTIVE STUDY 42
Left ventricular Systolic and diastolic function in rheumatoid arthritis 40
Left ventricular sistoli and diastolic function in outpatients affetected by rheumatoid arthritis 40
Studio ecocardiografico in pazienti affetti da artrite reumatoide. 39
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 39
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 39
STUDIO ECOCARDIOGRAFICO IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE 38
Left ventricular sistolic and diastolic function in rheumatoid arthritis. 38
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 36
Hepatitis C virus infection and primary Sjögren's Syndrome: A clinical and serologic description of 9 patients 35
The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort 35
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 34
Idiopathic inflammatory myopathies: Narrative review of unmet needs in clinical practice guidelines 33
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 31
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 29
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study 27
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 27
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 27
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 27
Ventricular-arterial coupling in systemic lupus erythematosus women without cardiovascular risk factors 21
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases 20
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 19
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment 17
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 17
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 16
Anti-Th/To antibodies in systemic sclerosis: analysis of long-term follow-up of pulmonary involvement, organ damage accrual and mortality in an Italian cohort with a case-control study 14
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 14
Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis 13
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 13
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 12
Totale 9.987
Categoria #
all - tutte 41.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.722 0 0 97 209 143 224 201 221 169 250 80 128
2020/20211.726 47 162 96 164 137 183 96 167 197 185 185 107
2021/20221.536 81 185 102 73 113 115 137 109 113 138 141 229
2022/20231.122 142 25 42 40 82 213 36 121 209 47 92 73
2023/20241.176 63 45 99 94 73 210 73 59 210 52 56 142
2024/2025170 61 73 36 0 0 0 0 0 0 0 0 0
Totale 10.031